• Erlotinib (NSC 718781): Targeting EGFR and SCUBE3-Driven Onc

  2026-07-23

  Explore how Erlotinib (NSC 718781) advances EGFR signaling pathway inhibition, with a unique focus on the interplay between EGFR and SCUBE3-mediated oncogenic processes. This article provides in-depth analysis and protocol guidance for researchers deploying Erlotinib in cancer model systems.

• Dacomitinib (PF-00299804) in Cancer Research: Applied Workfl

  2026-07-23

  Dacomitinib (PF-00299804) is a robust, irreversible pan-HER inhibitor that enables precise modulation of ErbB-driven signaling in resistant cancer models. This article delivers actionable workflows, protocol guidance, and troubleshooting strategies that empower researchers to maximize assay reproducibility and dissect apoptosis, cell cycle arrest, and mitochondrial responses in preclinical oncology.

• Antibody Targeting of SCUBE3 Impairs Oncogenic Signaling in

  2026-07-22

  This study identifies secretory SCUBE3 as a key driver of tumor growth, therapy resistance, and immune suppression across diverse cancers. Antibody-mediated inhibition of SCUBE3 disrupts oncogenic signaling and restores antitumor immunity, highlighting a promising pan-cancer therapeutic strategy.

• Paroxetine Mesylate: Applied SSRI and Kinase Inhibitor Workf

  2026-07-22

  Paroxetine Mesylate stands out as a multi-target tool for translational research, bridging neuropharmacology and oncology through selective serotonin reuptake inhibition and potent kinase modulation. This article delivers actionable protocols, troubleshooting wisdom, and data-driven context for maximizing assay performance with APExBIO's high-purity Paroxetine Mesylate.

• Estradiol–Receptor–Autophagy Axis: Organ Protection in Perim

  2026-07-21

  This study elucidates how reduced estradiol during perimenopause elevates cardiometabolic and renal risk, revealing that estrogen’s protective effects on the heart, aorta, and kidneys are mediated through receptor-driven autophagy pathways. The findings provide mechanistic insight relevant for precision hormone therapy and experimental modeling of estrogen receptor signaling.

• 7-AAD Cell Viability Assay Kit: Data-Driven Solutions for Ce

  2026-07-21

  This article addresses real-world cell viability assay challenges and demonstrates how the 7-AAD Cell Viability Assay Kit (SKU K2235) offers reproducible, multiplex-compatible, and workflow-friendly solutions. Benchmarked against common alternatives, the kit’s spectral precision and robust compatibility are highlighted for advanced cytometry and apoptosis studies. Readers gain actionable insight into optimizing cell viability analysis using validated, evidence-backed approaches.

• OSMI-1: Enabling Precision O-GlcNAc Transferase Inhibition i

  2026-07-20

  Explore how OSMI-1, a potent O-GlcNAc transferase inhibitor, empowers advanced research in placental biology, ferroptosis, and protein O-GlcNAc modification. This article reveals new experimental strategies, with actionable insights for optimizing O-GlcNAcylation research protocols.

• BMS 599626 Dihydrochloride: Molecular Insights into EGFR/Erb

  2026-07-20

  Explore how BMS 599626 dihydrochloride, a potent EGFR and ErbB2 inhibitor, enables advanced cancer and cellular senescence research. This article uniquely bridges mechanistic analysis with cutting-edge senolytic discovery and assay design.

• Applied Strategies for BMS 599626 dihydrochloride in EGFR an

  2026-07-19

  BMS 599626 dihydrochloride stands out as a nanomolar-potency EGFR and ErbB2 inhibitor, empowering rigorous cancer cell proliferation inhibition and translational tumor growth suppression studies. Its selectivity and protocol flexibility make it indispensable for breast and lung cancer research, as well as for dissecting senescence and oncogenic signaling workflows.

• JZL184: Optimizing Endocannabinoid Signaling in Bench Resear

  2026-07-18

  JZL184 empowers neuropharmacology and pain research with precise, selective MAGL inhibition—enabling robust modulation of endocannabinoid signaling and behavioral models. This guide delivers actionable workflows, protocol enhancements, and troubleshooting strategies to maximize reproducibility and interpretability in advanced assays.

• AG-490 (Tyrphostin B42): Dissecting JAK2/STAT6 in Tumor Immu

  2026-07-17

  Explore how AG-490 (Tyrphostin B42) enables precise inhibition of JAK2/STAT6 signaling, with unique insights into macrophage polarization and tumor microenvironment modulation. This article offers an advanced, scientifically grounded perspective for cancer research applications.

• METTL17-Mediated Mitochondrial Control of Ferroptosis in CRC

  2026-07-17

  The referenced study uncovers a novel role for the mitochondrial methyltransferase METTL17 in coordinating ferroptosis resistance and tumorigenesis in colorectal cancer (CRC). By regulating mitochondrial RNA methylation and translation, METTL17 emerges as a key mitochondrial defense node and a promising therapeutic target for sensitizing CRC cells to ferroptosis-based therapies.

• Dacomitinib (PF-00299804): Protocols for Pan-HER & Ferroptos

  2026-07-16

  Dacomitinib (PF-00299804) uniquely enables irreversible pan-HER inhibition, supporting advanced workflows in resistant cancer models. Recent mitochondrial ferroptosis insights unlock new combinatorial assay strategies, positioning Dacomitinib as a versatile tool for both mechanistic and translational oncology research.

• Dacomitinib (PF-00299804): Potent Pan-HER Inhibitor for Canc

  2026-07-16

  Dacomitinib (PF-00299804) is a highly selective, irreversible pan-HER inhibitor that targets EGFR, HER2, and HER4 with sub-100 nM potency, inducing apoptosis and sustained cell cycle arrest in resistant cancer models. Evidence demonstrates its efficacy in both in vitro and in vivo systems, especially in non-small-cell lung carcinoma and HER2-amplified breast cancer research.

• Calcitriol in Bench Research: Protocol Innovations and Troub

  2026-07-15

  Calcitriol, the active metabolite of vitamin D3, drives advanced research in bone, immune, and cellular signaling contexts. This guide delivers actionable protocol insights, troubleshooting strategies, and highlights the latest workflow innovations for leveraging Calcitriol in translational and mechanistic studies.

16200 records 1/1080 page Next 12345 下5页 Last page